Virtual Incision is a medical device company pioneering the first-of-its-kind, miniaturized surgical robot.
Virtual Incision is reimagining surgical robotics, with innovations offering mobility, flexibility and accessibility to minimally invasive options to more patients.
Virtual Incision was founded in 2006 by Dmitry Oleynikov and Shane Farritor. The company is headquartered in Lincoln, Nebraska, with an office in Pleasanton, California. The company is a spin-out of the University of Nebraska in Lincoln.
Virtual Incision’s robot platform features a small, self-contained surgical device that is inserted through a single midline umbilical incision in the patient’s abdomen.
Virtual Incision’s technology is designed to utilize existing tools and techniques familiar to surgeons, and does not require a dedicated operating room or specialized infrastructure.
Virtual Incision is backed by Genesis Innovation Group's cultivate(MD) Capital Fund II, LP, PrairieGold Venture Partners, Genesis Innovation Group and others. The company raised additional $20M in it's Series B round on Jan 08, 2020. This brings Virtual Incision's total funding to $64.7M to date.